Comments
Loading...
Imagion Biosystems Analyst Ratings and Price Targets | OTC:IBXXF | Benzinga
Imagion Biosystems Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Imagion Biosystems Corp from these most-recent analyst ratings.
Analyst Ratings for Imagion Biosystems
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Imagion Biosystems (IBXXF) stock?
There is no price target for Imagion Biosystems
What is the most recent analyst rating for Imagion Biosystems (IBXXF)?
There is no analyst for Imagion Biosystems
When was the last upgrade for Imagion Biosystems (IBXXF)?
There is no last upgrade for Imagion Biosystems
When was the last downgrade for Imagion Biosystems (IBXXF)?
There is no last downgrade for Imagion Biosystems.
When is the next analyst rating going to be posted or updated for Imagion Biosystems (IBXXF)?
There is no next analyst rating for Imagion Biosystems.
Is the Analyst Rating Imagion Biosystems (IBXXF) correct?
There is no next analyst rating for Imagion Biosystems.
Browse analyst ratings and price targets on all stocks.
